共 82 条
[1]
Burger M(2013)Epidemiology and risk factors of urothelial bladder cancer Eur Urol 63 234-241
[2]
Catto JW(2021)European association of urology guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2020 guidelines Eur Urol 79 82-104
[3]
Dalbagni G(2016)The diagnostic accuracy of 18F-fluorodeoxyglucose positron emission tomography and computed tomography in staging bladder cancer: a single-institution study and a systematic review with meta-analysis World J Urol 34 1229-1237
[4]
Witjes JA(2015)Local recurrence and progression of non-muscle-invasive bladder cancer in Sweden: a population-based follow-up study Scand J Urol 49 290-295
[5]
Bruins HM(2020)The Role of Imaging in Bladder Cancer Diagnosis and Staging Diagnostics (Basel) 10 703-2919
[6]
Cathomas R(2020)The role of [18F]FDG PET/CT in guiding precision medicine for invasive bladder carcinoma Front Oncol 10 565086-38
[7]
Soubra A(2020)Role of PET/CT in muscle-invasive bladder cancer Transl Androl Urol 9 2908-525
[8]
Hayward D(2021)Staging [18F]-fluorodeoxyglucose positron emission tomography/computed tomography changes treatment recommendation in invasive bladder cancer Eur Urol Oncol S2588–9311 00029-1491
[9]
Dahm P(2021)Comparison of 68Ga-DOTA-FAPI and [ Eur J Radiol. 142 109867-463
[10]
Liedberg F(2020)F]FDG PET/CT imaging modalities in the detection of liver metastases in patients with gastrointestinal system cancer Sci Rep 10 281-351